--- url: 'https://qubit.capital/blog/us-series-b-plus-weekly-funding-roundup-week-5-june-2026' title: 'US Series B+ Weekly Funding Roundup (Jun 22-29, 2026): $226.0M Raised Across 3 Deals' author: name: Vaibhav Totuka url: 'https://qubit.capital/blog/author/vaibhav-totuka' date: '2026-06-29T03:32:38+05:30' modified: '2026-06-29T11:25:36+05:30' type: post summary: 'US Series B+ startups raised $226M this week across 3 deals. Assort Health, Warp, and xCures detail investors, products, and what founders can learn.' categories: - Weekly Funding Roundup image: 'https://qubit.capital/wp-content/uploads/2026/06/featured-us-series-bplus-67960.webp' published: true --- # US Series B+ Weekly Funding Roundup (Jun 22-29, 2026): $226.0M Raised Across 3 Deals US late-stage startups raised $226.0 million this week across three deals. All three sell AI into stubborn, paperwork-heavy corners of the economy: patient access, payroll compliance, and medical records. Healthtech took two of the three rounds, and AI agents sat at the center of every pitch. Investors aren’t betting on chat interfaces here. They’re paying for software that completes real work, books appointments, files taxes, and structures clinical data, with humans freed from the busywork. The late-stage activity ran alongside a busy week earlier in the funnel. US seed-stage companies raised $65.0 million across two deals, and Series A startups pulled in $657.0 million across six. That Series A figure dwarfs the Series B+ total, a sign that fresh capital is flowing hardest into companies one stage behind these three. For the businesses below, the job now is converting funding into durable category leads before the next cohort catches up. Weekly Funding Roundup JUN 22-29, 2026 $226M TOTAL RAISED 3DEALS CLOSED MixedSTAGE $75.3MAVG DEAL SIZE USTOP REGION BY STAGE Series C$120M53% Series B$106M47% BY SECTOR Assort HealthHealthtech, AI voice agents$120M WarpSaaS, HCM and payroll$60M xCuresHealthtech, clinical data$46M Table of Contents - [1. Assort Health Raises $120M For Healthcare Voice AI](#1-assort-health-raises-$120m-for-healthcare-voice-ai) [Deal Overview](#deal-overview) - [Investor Profile](#investor-profile) - [Company and Leadership](#company-and-leadership) - [Problem and Opportunity](#problem-and-opportunity) - [Product and Technology](#product-and-technology) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision) - [Market Context](#market-context) - [2. Warp Raises $60M To Rebuild Payroll And HR](#2-warp-raises-$60m-to-rebuild-payroll-and-hr) [Deal Overview](#deal-overview-1) - [Investor Profile](#investor-profile-1) - [Company and Leadership](#company-and-leadership-1) - [Problem and Opportunity](#problem-and-opportunity-1) - [Product and Technology](#product-and-technology-1) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-1) - [Market Context](#market-context-1) - [3. xCures Raises $46M To Organize Medical Records](#3-xcures-raises-$46m-to-organize-medical-records) [Deal Overview](#deal-overview-2) - [Investor Profile](#investor-profile-2) - [Company and Leadership](#company-and-leadership-2) - [Problem and Opportunity](#problem-and-opportunity-2) - [Product and Technology](#product-and-technology-2) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-2) - [Market Context](#market-context-2) - [Lessons For Founders](#lessons-for-founders) ## 1. Assort Health Raises $120M For Healthcare Voice AI ### Deal Overview - Stage: Series C - Sector: Healthtech, AI voice agents - Geography: United States - Round size: $120M - Valuation: $1.2B ### Investor Profile [Assort Health](https://www.assorthealth.com) raised its $120M Series C led by Menlo Ventures, with Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Tau Ventures, and Quiet Capital joining. NFL quarterback Joe Montana also put in money as an angel. Menlo’s JP Sanday took a board seat. Total funding now passes $222M. Menlo leading at a $1.2 billion valuation signals conviction that patient access is a platform, not a feature. The investor mix pairs deep healthtech operators with brand-name angels who open doors with health systems. ### Company and Leadership Assort started as the first voice AI agent built to schedule a specialty medical appointment. It has since grown into a full patient-access platform. Revenue climbed roughly 20x over the prior 15 months. The company reports about $3.3M in annual revenue impact per 100 providers it serves. ### Problem and Opportunity Medical front desks drown in calls. Staffing shortages and rising patient volumes leave appointments unbooked and clinicians buried in admin. Legacy phone trees route calls but resolve nothing, so patients wait on hold or give up. ### Product and Technology Assort builds AI voice agents that handle the whole patient journey instead of just routing calls. The platform covers 24/7 scheduling, triage, intake, after-hours coverage, medication refills, lab requests, referral automation, insurance eligibility checks, and payments. It integrates with 15+ EHR and practice-management systems across 20+ specialties. Its proprietary model, Synapse, learns specialty workflows across every deployment, then generates the edge cases and tests each new site needs. The data behind it runs deep: 190 million-plus patient interactions, 62,000 care protocols, and 1.6 million decision pathways. Each deployment feeds the model, which makes the next one sharper. ### Use of Proceeds and Vision The $120M funds expansion across more specialties, health systems, and patient-access workflows. Assort will deepen payments, referrals, and document processing, keep developing Synapse, and push go-to-market. The aim is to own patient access as horizontal infrastructure. ### Market Context AI voice agents in healthcare was about a $639M market in 2025, growing near 37.8% a year through 2030. Competitors include Infinitus Systems, Hippocratic AI, Zocdoc, and Cedar. The race is on to move from single-task automation to full patient-journey platforms. ## 2. Warp Raises $60M To Rebuild Payroll And HR ### Deal Overview - Stage: Series B - Sector: SaaS, HCM and payroll - Geography: United States - Round size: $60M - Total funding: $85M ### Investor Profile [Warp](https://www.warp.co) raised $60M led by Battery Ventures, with Peak XV, Sound Ventures, and Y Combinator participating. The round came together in six days and brings total funding to $85M in under a year. Battery makes the case bluntly: the US still employs roughly 150,000 people in payroll operations, and Warp’s agents are built to displace that manual work. ### Company and Leadership Warp was founded in 2023 out of Y Combinator and is based in New York City with an in-office team. CEO Ayush Sharma is an MIT graduate and former ML engineer who ran payroll himself at a prior startup and felt the multi-state tax pain directly. ### Problem and Opportunity Payroll and compliance break down once a company hires across states. Tax registrations, unemployment setup, quarterly filings, and government notices pile up. Incumbents like ADP and Workday handle scale but bury customers in implementation and overhead. ### Product and Technology Warp is one AI-native platform for companies of 5 to 5,000 employees. It runs payroll across all 50 states and 150+ countries, moves new hires from offer to active in under 10 minutes, and centers on compliance. AI agents monitor 10,000+ jurisdictions and handle registrations, workers’ comp, and tax notices on their own, with the company claiming $100M-plus in penalties saved. The efficiency edge is the story. Warp says it serves about 380 businesses with one part-time contractor on compliance, while Gusto reportedly devotes around 30% of its workforce to the same job. The bet is that LLMs can now read ambiguous government notices and reason through tax edge cases that kept humans in the loop for decades. ### Use of Proceeds and Vision Proceeds go to deeper AI agents, broader tax and compliance coverage, new products like Benefits Brokerage and Warp Fabric, and growing the New York team from about 50 to 200 people. ARR doubled in Q1, and Warp is on track for $2 billion-plus in annual payroll volume in 2026, with customers skewing toward AI startups. ### Market Context The HCM and payroll market sits near $21.9 billion in 2026. Warp positions against Workday and Rippling while framing ADP, Paycom, and Paylocity as legacy systems that buckle under multi-state complexity. One open risk: Warp hasn’t yet built the state-by-state money-transmitter-license infrastructure that gives Gusto a deeper regulatory moat. ## 3. xCures Raises $46M To Organize Medical Records ### Deal Overview - Stage: Series B - Sector: Healthtech, clinical data - Geography: United States - Round size: $46M - Valuation: $127M post-money ### Investor Profile [xCures](https://www.xcures.com) raised $46M led by Innovius Capital, with iGrow and Spring Mountain Capital, at a reported $127M post-money valuation. Total funding now tops $76M. The investor thesis is direct: trustworthy data is the precondition for using AI in healthcare, and xCures sells exactly that. ### Company and Leadership xCures was founded in 2018 in San Francisco, spun out of Cancer Commons. It began helping advanced-cancer patients find treatment options, then hit a wall when records arrived in FedEx boxes and over fax machines. That bottleneck pushed it into data infrastructure. Founders include Marty Tenenbaum and Jeff Shrager, with Mika Newton as CEO. ### Problem and Opportunity About 80% of healthcare data is unstructured: free-text notes, scanned PDFs, faxes. That fragmentation blocks clinical decisions and stalls AI projects before they start. Records sit scattered across hundreds of thousands of sites with no reliable way to pull them together. ### Product and Technology The flagship is the Clinical Clarity Engine. It ingests messy records and returns structured, source-linked, decision-ready data, aggregating from 550,000-plus healthcare sites with output in about 15 minutes. Every answer links back to its exact source, so a user can verify it in one click, a deliberate rejection of black-box models. The moat is sourcing. xCures uses TEFCA-native, patient-mediated access, where patients authorize retrieval rather than the company negotiating provider by provider. It has processed 300 million-plus records and supported decisions for millions of patients. ### Use of Proceeds and Vision The $46M accelerates product development, expands the team for a growing 2027 pipeline, and scales the engine to more organizations. xCures reportedly hit cash-flow breakeven in 2025, so it’s raising to grow faster, not to survive. It wants to be the clinical clarity layer for healthcare data across every therapeutic area. ### Market Context xCures targets the real-world evidence market, worth about $4.74 billion in 2024 and projected to reach $10.8 billion by 2030. ARR grew from roughly $3M to $10M in 2025 and is projected past $20M in 2026, with around 25 enterprise customers. Incumbents include IQVIA, Datavant, and Tempus AI, but xCures’ patient-mediated model sources data differently. ## Lessons For Founders - Sell completed work, not features. All three winners pitched agents that finish tasks end to end, booking appointments, filing taxes, structuring records, rather than tools that hand work back to the user. - Make your data compound. Assort’s Synapse and xCures’ source-linked engine both get better with every deployment, turning early customers into a lead competitors can’t quickly copy. - Speed signals conviction. Warp closed $60M in six days. A tight metric story and a clear thesis let investors move fast when the market is hot. - Pick a structural edge, then name your moat’s weak spot. Warp’s team openly flags the licensing gap versus Gusto. Knowing where you’re exposed is part of earning the round. - Raise to accelerate, not to survive. xCures reached breakeven before this round, which let it raise on its own terms and frame the capital as fuel rather than a lifeline.